VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

58 hedge funds and large institutions have $52.8M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$627K
Puts
$235K
Net Calls
Net Calls Change

Top Buyers

1 +$4.25M
2 +$884K
3 +$625K
4
BlackRock
BlackRock
New York
+$513K
5
BCM
Bridgeway Capital Management
Texas
+$107K

Top Sellers

1 -$726K
2 -$708K
3 -$370K
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$153K
5
E
Ergoteles
New York
-$97.8K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$2K
52
$1K
53
$1K
54
55
56
57
58
59
60